The use of placebos in randomized clinical trials of mood disorders: well justified, but improvements in design are indicated
- 1 April 2000
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 47 (8) , 687-688
- https://doi.org/10.1016/s0006-3223(00)00845-3
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Placebo control groups in randomized treatment trials: a statistician’s perspectiveBiological Psychiatry, 2000
- The national depressive and manic-depressive association: an introductionBiological Psychiatry, 2000
- Placebo-controlled trials in psychiatric research: an ethical perspectiveBiological Psychiatry, 2000
- Efficient trial designs to reduce placebo requirementsBiological Psychiatry, 2000
- Special issues in trial design and use of placebo in bipolar illnessBiological Psychiatry, 2000
- Use of placebo control groups in evaluating efficacy of treatment of unipolar major depressionBiological Psychiatry, 2000
- Placebo effect in randomized, controlled studies of acute bipolar mania and depressionBiological Psychiatry, 2000
- Placebo effect in randomized, controlled maintenance studies of patients with bipolar disorderBiological Psychiatry, 2000
- Problems in interpreting active control equivalence trialsAccountability in Research, 1996
- The Continuing Unethical Use of Placebo ControlsNew England Journal of Medicine, 1994